Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

Agios Pharmaceuticals, Inc. (AGIO)

-NasdaqGS
40.67 Up 1.46(3.72%) Apr 17, 4:00PM EDT
Get the big picture on all your investments.
Insider RosterGet Insider Roster for:
Insider Holders*
Individual/EntityMost Recent Trans.Shares Owned as of Trans. Date
ARCH VENTURE FUND VII LP
Beneficial Owner (10% or more)
Acquisition (Non Open Market)
Jul 29, 2013
3,860,738
Jul 29, 2013
BILLER SCOTT
Officer
Automatic Sale
Apr 1, 2014
30,000
Apr 1, 2014
CANTLEY LEWIS CLAYTON JR.
Director
Ownership Statement
Jul 23, 2013
363,636
Jul 23, 2013
CELGENE EUROPEAN INVESTMENT CO LLC
Beneficial Owner (10% or more)
Acquisition (Non Open Market)
Jul 29, 2013
4,719,259
Jul 29, 2013
COLE DOUGLAS G.
Director
Ownership Statement
Jul 23, 2013
0
Jul 23, 2013
FLAGSHIP VENTURES FUND 2007, L.P.
Beneficial Owner (10% or more)
Acquisition (Non Open Market)
Jul 29, 2013
3,860,738
Jul 29, 2013
GODDARD GLENN
Officer
Option Exercise
Apr 7, 2014
0
Apr 7, 2014
HIGGONS JOHN DUNCAN
Officer
Option Exercise
Apr 7, 2014
209,090
Apr 7, 2014
KARSEN PERRY A
Director
Ownership Statement
Jul 23, 2013
0
Jul 23, 2013
MAK TAK W.
Beneficial Owner (10% or more)
Ownership Statement
Jul 23, 2013
545,454
Jul 23, 2013
MARAGANORE JOHN
Director
Purchase
Jul 24, 2013
44,333
Jul 24, 2013
NELSEN ROBERT
Director
Acquisition (Non Open Market)
Jul 29, 2013
3,860,738

Jul 29, 2013
SCHENKEIN DAVID P
Officer
Option Exercise
Mar 25, 2014
266,272

Mar 25, 2014
STARR KEVIN P
Director
Acquisition (Non Open Market)
Jul 29, 2013
5,564,414

Jul 29, 2013
TESSIER-LAVIGNE MARC
Director
Purchase
Jul 24, 2013
101,009
Jul 24, 2013
THIRD ROCK VENTURES LP
Beneficial Owner (10% or more)
Acquisition (Non Open Market)
Jul 29, 2013
5,564,414
Jul 29, 2013

View Transactions for Insiders & Institutional Holders

 
* Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.